# 3892
Adjuvants are additives to vaccines, designed to enhance the body’s immune response, and reduce the amount of antigen needed per shot.
While they are not used in any of the flu vaccines offered in the United States right now, they are part of the vaccine mix for Canada, the UK, Europe, and much of the rest of the world.
Helen Branswell, ace medical reporter for The Canadian Press, gives us a Q&A session on vaccine adjuvants today. One that will hopefully dispel some of the myths, rumors, and concerns that surround them.
This report from the Toronto Sun.
Flu vaccine additive helps immune system
By Helen Branswell, THE CANADIAN PRESS
Last Updated: 26th October 2009, 3:07pmSix months ago, most Canadians probably didn’t know what a vaccine adjuvant was.
But now, as Canadians and many Europeans mull over whether to line up for an H1N1 flu shot that includes an adjuvant, many have Googled this addition to their vocabularies. And lots are wondering whether they are comfortable with the idea of having vaccine mixed with one of these additives injected into their arms.
Ms. Branswell asks, and answers the following questions for her readers:
Q: What is an adjuvant?
Q: Why is Canada buying adjuvanted vaccine?
Q: So we’re using vaccine with adjuvant to benefit someone else?
Q: But what’s this about adjuvanted flu shots hurting more?
Q: What is the safety record for adjuvants?
Q: What are adjuvants made from?
Q: Isn’t squalene dangerous? Didn’t it cause Gulf War Syndrome?
Q: What’s that about autoimmune disease?
Q: Squalene used commercially is sourced from shark’s liver. Does that mean people with fish allergies should avoid this vaccine?
Related Post:
- Branswell On Flu Vaccine Matches
- mBio: Coronavirus Has An Affinity For Multiple Hosts
- Branswell On Expanded Surveillance For The Coronavirus
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- SARS Virus Placed On Select Agents List
- Branswell Updates The Novel Coronavirus Story
- Osterholm: Time To Close The Pig Barns
- Branswell On Lifting The H5N1 Research Moratorium
- Pediatrics: Low Uptake Of Flu Vaccine Among Toddlers In Ontario
- NSABB Clears H5N1 Studies For Publication
- NSABB To Re-examine H5N1 Research Risks
- Branswell: WHO Hopes H5N1 Studies Can Be Published By Summer
- Branswell On The Transmissibility Of The H3N2v Virus
- Branswell On the CFR Of H5N1
- Eurosurveillance: Older People May Be Susceptible To The H3N2v Virus
- WHO: Will Host H5N1 Talks In Geneva
- Branswell On The Research Moratorium
- Branswell: WHO on H5N1 Research Controversy
- Publish or Perish The Thought?
- Three Would Make For A Crowded Viral Field
- Branswell: PLoS One Study On Adverse Reactions To MMR Vaccine
- Branswell On The New trH3N2 Flu Virus
- CIDRAP: New Details In The trH3N2 Story
- Branswell On The WHO Response To trH3N2
- More Details On The trH3N2 Story
- NEJM: Adjuvanted Flu Vaccine Found Effective In Children
- Pediatrics: Effectiveness Of A Single Adjuvanted Pandemic Flu Shot In Children
- BMJ: Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine
- Lancet: Immunogenicity and safety Of Adjuvanted Flu Vaccines
- BMJ: Immunogenicity Of Adjuvanted vs. Unadjuvanted H1N1 Vaccines
- Novartis To Open Next Generation Vaccine Plant In NC
- Referral: Fergus Walsh Pandemrix Vaccine Q&A
- SAGE Advice
- Canada Purchases Unadjuvanted Vaccine From CSL
- Branswell Reports On Canada’s Unadjuvanted Vaccine Purchase
- David Dobbs Examines The Adjuvant Controversy
- Branswell: Feds Between Rock & Hard Place On Vaccines
- Canada To Offer Unadjuvanted Vaccine To Pregnant Women
- Canada Releases Tamiflu From National Emergency Stockpile
- Canada: FluWatch Week 52
- Canada: Another West Coast Temblor
- Haida Gwaii Quake & Tsunami Advisories
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Ontario Confirms H1N1v Case
- EID Journal: Revisiting The `Canadian Problem’
- Alberta, Canada Issues Measles Alert
- IDSA: Educational Guidelines Lower Antibiotic Use
- Webinar: pH1N1 – H3N2 A Novel Influenza Reassortment
- North America Flu Surveillance Week 8
- North America Influenza Surveillance - Week 4
- North America: Flu Surveillance Week 2
- North America: Flu Activity Week 1
- Toronto ERs Seeing Heavy Flu Volume
- North America: H3N2 Driving Our Flu Season
- PHAC: Lessons Learned From The 2009 Pandemic
- Ontario: A Top Ten List Of Infectious Disease Threats
- Eurosurveillance: The Temporary Immunity Hypothesis
- OIE Report: Manitoba Bird Flu Identified As H5N2
- CFIA Statement On Manitoba’s Avian Flu Outbreak
- CTV Reporting Low Path H5 On Canadian Turkey Farm
- CMAJ: Comparing First And Second Pandemic Waves In Canada
- Study: Eurosurveillance On `The Canadian Problem’
- CSA White Paper: Voices From The Front Lines
Widget by [ Iptek-4u ]